Vulnerability in Insulet Omnipod Insulin Management System
CVE-2020-10627
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L.
EPSS exploit prediction
EPSS 0.005, 42.6th percentile (scored ); unchanged over 30 days. About EPSS.
Affected products
- Insulet Omnipod Insulin Management System — versions 19191, 40160, ZXP425
- Insulet Omnipod Insulin Management System Firmware
Weakness classification (CWE)
Public exploits and proof-of-concept code
Also mentioned in 1 other repository (Live-Hack-CVE/CVE-2020-10627). These reference the CVE in a list, notes or a scanner and are not exploit code for it.
References
- us-cert.cisa.gov/ics/advisories/icsma-20-079-01 (US Government Resource, Third Party Advisory)
- www.myomnipod.com/security-bulletins (Vendor Advisory)